Welcome to the first map of human biology

Insight

Human biology has a dynamic landscape. In order to successfully treat a patient, every new drug has to navigate this terrain.

Traditional drug discovery ignores that landscape. Most drugs are designed to navigate the terrain of animals - not humans - and pharma gambles billions of dollars, over a decade of time, and hundreds of millions of animal lives that the terrains are similar enough.

The result: an astonishing 97% of drugs fail in human trials. And every year pharma places their same bets, drug prices shoot up another 10% - while countless diseases remain untreated.

Platform

Parallel Bio reimagined the entire drug discovery process from the ground up - creating a system that charts the map of human biology. A system that’s population-scale, perturbable, and fully human - with the power to reveal the biological landscape of any disease.

This biological atlas is built entirely on human data, using groundbreaking new biological and computational tools to rapidly chart what has been previously impossible to map.

These tools - combined with a growing biobank of patient samples - generate compounding proprietary data, transforming drug discovery today and paving the path to a new era of human health.

Proof

We're working with numerous companies at the forefront of biology, including three Fortune 500 companies. Learn about the future today.

50+

Compounds tested

170+

Unique patient backgrounds modeled

87%

Concordance with human outcomes

1 Phase 1 trial informed by our data

10x

Faster than traditional drug discovery

1000x

Lower costs

Animals killed

What we do

Introducing human-first drug discovery

Drug discovery

We’ve re-written the entire process of drug discovery, using our map of human biology to go from disease target discovery to IND in a fraction of the time and cost

Precision medicine

Accurate maps of human biology unlock personalized insights and patient stratification in ways never previously possible

Foundation models

Our closed loop, end-to-end automation is an engine of continuous data generation, creating a flywheel to build one of the largest sets of human biological data - with endless potential